Depression Treatment in Lahore: Symptoms, Causes, Diagnosis and Evidence-Based Treatment

Depression is one of the most common mental health conditions worldwide, and one of the most treatable. The World Health Organization estimates that depression affects more than 280 million people globally, making it a leading cause of disability. Despite its prevalence, depression often goes unrecognised or untreated, particularly where stigma discourages people from seeking help.

Dr. Muhammad Shoaib Zafar provides confidential, evidence-based assessment and treatment for all forms of depression, from a first mild episode to complex, treatment-resistant presentations.

Clinical depression, or Major Depressive Disorder, is more than temporary sadness. It is a persistent change in mood, thinking, and physical functioning lasting at least two weeks, significant enough to affect daily life, relationships, and work or academic performance.

Core symptoms include persistent low mood and loss of interest or pleasure in activities previously enjoyed. Additional symptoms commonly include:

Depression arises from an interaction of biological, psychological, and social factors. Biological contributors include genetics, neurotransmitter changes (particularly involving serotonin and norepinephrine), and hormonal changes. Psychological contributors include unhelpful thinking patterns and past adverse experiences. Social contributors include chronic stress, loss, isolation, and major life changes.

Diagnosis is based on a detailed clinical interview, applying DSM-5 criteria: at least five characteristic symptoms present for two weeks or more, including low mood or loss of interest, causing significant distress or impairment. The PHQ-9, a validated nine-item questionnaire, is commonly used to support assessment and monitor treatment response over time.

Differential diagnosis considers other conditions that can present similarly, including bipolar disorder (where depressive episodes alternate with mania or hypomania), thyroid dysfunction, and adjustment disorder with depressed mood, since management differs meaningfully between these conditions.

Treatment is individualised based on severity, prior treatment response, and patient preference.

Antidepressants, most commonly SSRIs (selective serotonin reuptake inhibitors) and SNRIs (serotonin-norepinephrine reuptake inhibitors), are first-line pharmacological treatment for moderate to severe depression. Other classes may be used depending on symptom profile, prior response, and tolerability. Medication is typically continued for a number of months after recovery to reduce relapse risk.

Cognitive Behavioural Therapy (CBT) and Interpersonal Therapy have the strongest evidence base for depression, either alone for mild-to-moderate cases or combined with medication for moderate-to-severe cases.

For treatment-resistant depression that has not responded to adequate trials of medication and psychotherapy, TMS is a non-invasive, evidence-based option that stimulates specific brain regions involved in mood regulation.

Regular physical activity, consistent sleep routines, reduced alcohol use, and social engagement meaningfully support recovery alongside clinical treatment.

Because depression can recur, treatment plans typically include relapse-prevention strategies — recognising early warning signs, maintaining treatment gains, and, for some patients with recurrent depression, longer-term maintenance medication.

Dr. Muhammad Shoaib Zafar is a Consultant Psychiatrist with experience managing the full range of depressive presentations, from a first mild episode to complex, treatment-resistant, or postpartum depression, using an individualised combination of medication, psychotherapy, and, where indicated, TMS.

This page is provided for general educational purposes and does not replace an individual psychiatric assessment. If you are experiencing symptoms of depression, or thoughts of self-harm or suicide, please seek a confidential professional assessment.